Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone m… Read more
Avantor Inc (AVTR) - Net Assets
Latest net assets as of December 2025: $5.57 Billion USD
Based on the latest financial reports, Avantor Inc (AVTR) has net assets worth $5.57 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.79 Billion) and total liabilities ($6.23 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.57 Billion |
| % of Total Assets | 47.18% |
| Annual Growth Rate | N/A |
| 5-Year Change | 32.59% |
| 10-Year Change | N/A |
| Growth Volatility | 19.61 |
Avantor Inc - Net Assets Trend (2016–2025)
This chart illustrates how Avantor Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Avantor Inc (2016–2025)
The table below shows the annual net assets of Avantor Inc from 2016 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $5.57 Billion | -6.58% |
| 2024-12-31 | $5.96 Billion | +13.40% |
| 2023-12-31 | $5.25 Billion | +8.18% |
| 2022-12-31 | $4.86 Billion | +15.69% |
| 2021-12-31 | $4.20 Billion | +56.94% |
| 2020-12-31 | $2.67 Billion | +8.61% |
| 2019-12-31 | $2.46 Billion | +180.68% |
| 2018-12-31 | $-3.05 Billion | -16.47% |
| 2017-12-31 | $-2.62 Billion | -413.16% |
| 2016-12-31 | $-510.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Avantor Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 167850000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.67 Billion | 30.06% |
| Common Stock | $3.98 Billion | 71.60% |
| Other Comprehensive Income | $-16.90 Million | -0.30% |
| Total Equity | $5.57 Billion | 100.00% |
Avantor Inc Competitors by Market Cap
The table below lists competitors of Avantor Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NEPI Rockcastle PLC
AS:NRP
|
$5.18 Billion |
|
Ingenic Semiconductor
SHE:300223
|
$5.18 Billion |
|
Everus Construction Group Inc
NYSE:ECG
|
$5.18 Billion |
|
Hengli Petrochemical Co Ltd
SHG:600346
|
$5.19 Billion |
|
Wingstop Inc
NASDAQ:WING
|
$5.18 Billion |
|
CAR Group Ltd
AU:CAR
|
$5.18 Billion |
|
AVIC Jonhon Optronic Technology Co Ltd
SHE:002179
|
$5.17 Billion |
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
$5.17 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Avantor Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,956,700,000 to 5,565,000,000, a change of -391,700,000 (-6.6%).
- Net loss of 530,200,000 reduced equity.
- Share repurchases of 80,700,000 reduced equity.
- Other comprehensive income increased equity by 167,100,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-530.20 Million | -9.53% |
| Share Repurchases | $80.70 Million | -1.45% |
| Other Comprehensive Income | $167.10 Million | +3.0% |
| Other Changes | $52.10 Million | +0.94% |
| Total Change | $- | -6.58% |
Book Value vs Market Value Analysis
This analysis compares Avantor Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.96x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-0.76 | $7.80 | x |
| 2017-12-31 | $-5.28 | $7.80 | x |
| 2018-12-31 | $-6.15 | $7.80 | x |
| 2019-12-31 | $6.14 | $7.80 | x |
| 2020-12-31 | $4.58 | $7.80 | x |
| 2021-12-31 | $7.00 | $7.80 | x |
| 2022-12-31 | $7.15 | $7.80 | x |
| 2023-12-31 | $7.74 | $7.80 | x |
| 2024-12-31 | $8.74 | $7.80 | x |
| 2025-12-31 | $8.16 | $7.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Avantor Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.53%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.09%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 2.12x
- Recent ROE (-9.53%) is below the historical average (4.22%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -6.13% | 0.61x | 0.00x | $-4.91 Million |
| 2017 | 0.00% | -9.03% | 0.12x | 0.00x | $149.32 Million |
| 2018 | 0.00% | -1.48% | 0.59x | 0.00x | $218.27 Million |
| 2019 | 1.54% | 0.63% | 0.62x | 3.97x | $-208.42 Million |
| 2020 | 4.36% | 1.82% | 0.65x | 3.70x | $-150.83 Million |
| 2021 | 13.64% | 7.75% | 0.53x | 3.31x | $152.90 Million |
| 2022 | 14.14% | 13.98% | 0.36x | 2.77x | $200.96 Million |
| 2023 | 6.11% | 4.61% | 0.54x | 2.47x | $-204.16 Million |
| 2024 | 11.94% | 10.49% | 0.56x | 2.03x | $115.83 Million |
| 2025 | -9.53% | -8.09% | 0.56x | 2.12x | $-1.09 Billion |
Industry Comparison
This section compares Avantor Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Avantor Inc (AVTR) | $5.57 Billion | 0.00% | 1.12x | $5.18 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |